Product Specification
Host |
Rabbit |
Antigen |
Cytokeratin 7 |
Synonyms |
Cytokeratin-7 (CK-7), Keratin-7 (K7), Sarcolectin, Type-II keratin Kb7, KRT7 |
Immunogen |
Synthetic Peptide |
Location |
Cytoplasm |
Accession |
P08729 |
Clone Number |
SDT-121-17 |
Antibody Type |
Rabbit mAb |
Application |
WB, IHC-P, ICC, FCM, IP, IF |
Reactivity |
Hu |
Purification |
Protein A |
Concentration |
0.5mg/ml |
Physical Appearance |
Liquid |
Storage Buffer |
PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300 |
Stability & Storage |
12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application |
dilution |
species |
IP |
1:25 |
|
ICC |
1:500 |
|
IHC-P |
1:500 |
|
FCM |
1:500 |
|
WB |
1:1000 |
|
IF |
1:200 |
|
Background
Cytokeratin 7 is the intermediate silk protein mainly expressed in epithelial cells. The heterodine of keratin consists of a polymerization filament by an acid -keratin (or type I keratin, keratin 9 to 23) and alkaline keratin (or type II keratin, keratin 1 to 8). Expression similar to but more limited than keratins 8 and 18 in simple, pseudostratified and ductal epithelium, mesothelium and urothelium.It's enerally expressed (with some variation) in adenocarcinoma of lung, breast, thyroid, endometrium, cervix, ovary, salivary gland, upper GI tract, urothelial carcinoma, papillary renal cell carcinoma and Paget disease
It's generally negative (with some variation) in colorectal carcinoma, Merkel cell carcinoma, hepatocellular carcinoma, prostatic adenocarcinoma, adrenocortical tumors and squamous cell carcinoma.